Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, January 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 121 articles:
HTML format


 

Single Articles

  1. ZHANG YT, Xue JJ, Wang Q, Cheng SY, et al
    Dehydroepiandrosterone attenuates pulmonary artery and right ventricular remodeling in a rat model of pulmonary hypertension due to left heart failure.
    Life Sci. 2018 Dec 31. pii: S0024-3205(18)30857.
    Abstract    

    Abstract available

  2. SENGUPTA S, Dey D, Bhattacharyya P
    Correlating between chronic obstructive pulmonary disease assessment test and emPHasis score in Group III pulmonary hypertension patients.
    Lung India. 2019;36:86-87.
    Abstract    



  3. SULIMAN HB, Nozik-Grayck E
    Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.
    Antioxid Redox Signal. 2019 Jan 3. doi: 10.1089/ars.2018.7705.
    Abstract    

    Abstract available

  4. CHENG CY, Zhang YX, Denas G, Du Y, et al
    Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Intern Emerg Med. 2019 Jan 2. pii: 10.1007/s11739-018-02021.
    Abstract    

    Abstract available

  5. CHEN C, Liu J, Liu Z, He X, et al
    Electrocardiogram signs of right ventricular hypertrophy may help identify pulmonary hypertension in patients with dilated cardiomyopathy.
    Int J Cardiol Heart Vasc. 2018;22:61-66.
    Abstract    

    Abstract available

  6. LINDHOLM A, Hesselstrand R, Radegran G, Arheden H, et al
    Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Clin Physiol Funct Imaging. 2018 Dec 31. doi: 10.1111/cpf.12561.
    Abstract    

    Abstract available

  7. MIRI M, Hejazi S, Maghsoudlou F, Ahmadi M, et al
    Prevalence of Pulmonary Hypertension in End-stage Renal Disease Patients Undergoing Hemodialysis and Peritoneal Dialysis at a Referral Center in Mashhad, Iran, From 2015 to 2016.
    Iran J Kidney Dis. 2018;12:364-368.
    Abstract    

    Abstract available

  8. HUA C, Zhao J, Wang H, Chen F, et al
    Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies.
    Biomed Pharmacother. 2018;107:937-944.
    Abstract    

    Abstract available

  9. POTUS F, Hindmarch CCT, Dunham-Snary KJ, Stafford J, et al
    Transcriptomic Signature of Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension: Deep Sequencing Demonstrates Mitochondrial, Fibrotic, Inflammatory and Angiogenic Abnormalities.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  10. LACHANT DJ, Meoli DF, Haight D, Lyons JA, et al
    Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.
    Exp Lung Res. 2018;44:51-61.
    Abstract    

    Abstract available

  11. KANAOKA K, Horii M, Nagato H, Kaneda K, et al
    A giant pulmonary artery aneurysm.
    Eur Heart J Cardiovasc Imaging. 2018;19:236.
    Abstract    



  12. MAGON W, Stepniewski J, Miszalski-Jamka T, Urbanczyk-Zawadzka M, et al
    Right Ventricular Epicardial Vascularisation in Patients With Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2018;27:1428-1436.
    Abstract    

    Abstract available

  13. REHMAN MB, Howard LS, Christiaens LP, Gill D, et al
    Resting right ventricular function is associated with exercise performance in PAH, but not in CTEPH.
    Eur Heart J Cardiovasc Imaging. 2018;19:185-192.
    Abstract    

    Abstract available

  14. PLOEGSTRA MJ, Brokelman JGM, Roos-Hesselink JW, Douwes JM, et al
    Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.
    Eur Heart J Cardiovasc Imaging. 2018;19:216-224.
    Abstract    

    Abstract available

  15. ZHU L, Xiao R, Zhang X, Lang Y, et al
    Spermine on Endothelial Extracellular Vesicles Mediates Smoking-Induced Pulmonary Hypertension Partially Through Calcium-Sensing Receptor.
    Arterioscler Thromb Vasc Biol. 2019 Jan 10:ATVBAHA118312280.
    Abstract    

    Abstract available

  16. NOORBAKHSH KA, Bell-Cheddar YR, Marin JR
    Focused Cardiac Ultrasound in Pediatric Pulmonary Hypertension.
    Pediatr Emerg Care. 2019 Jan 7. doi: 10.1097/PEC.0000000000001700.
    Abstract    

    Abstract available

  17. JACOBS ER, Narayanan J, Fish BL, Gao F, et al
    Cardiac Remodeling and Reversible Pulmonary Hypertension During Pneumonitis in Rats after 13-Gy Partial-Body Irradiation with Minimal Bone Marrow Sparing: Effect of Lisinopril.
    Health Phys. 2019 Jan 8. doi: 10.1097/HP.0000000000000919.
    Abstract    

    Abstract available

  18. HAMATANI Y, Amaki M, Yonezawa R, Yanagi Y, et al
    Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy.
    Int J Cardiovasc Imaging. 2019 Jan 8. pii: 10.1007/s10554-018-01522.
    Abstract    

    Abstract available

  19. TANG H, Wu K, Wang J, Vinjamuri S, et al
    Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2018;3:744-762.
    Abstract    

    Abstract available

  20. HE Q, Nan X, Li S, Su S, et al
    Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells.
    Biomed Res Int. 2018;2018:9504158.
    Abstract    

    Abstract available

  21. MORADI F, Morris TA, Hoh CK
    Perfusion Scintigraphy in Diagnosis and Management of Thromboembolic Pulmonary Hypertension.
    Radiographics. 2019;39:169-185.
    Abstract    

    Abstract available

  22. CHEONG HI, Farha S, Park MM, Thomas JD, et al
    Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:180.
    Abstract    

    Abstract available

  23. VISWANATHAN G, Mamazhakypov A, Schermuly RT, Rajagopal S, et al
    The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:179.
    Abstract    

    Abstract available

  24. KARMOUTY-QUINTANA H, Guignabert C, Kwapiszewska G, Ormiston ML, et al
    Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.
    Front Physiol. 2018;9:1777.
    Abstract    



  25. HSU S
    Coupling Right Ventricular-Pulmonary Arterial Research to the Pulmonary Hypertension Patient Bedside.
    Circ Heart Fail. 2019;12:e005715.
    Abstract    



  26. WIEDENROTH CB
    Multimodality treatment for chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2018 Dec 29. pii: S0167-5273(18)36195.
    Abstract    



  27. WANG J, Tian XT, Peng Z, Li WQ, et al
    HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Vascul Pharmacol. 2019 Jan 2. pii: S1537-1891(18)30358.
    Abstract    

    Abstract available

  28. THAYER TE, Huang S, Levinson RT, Farber-Eger E, et al
    Unbiased Phenome-wide Association Studies of Red Cell Distribution Width Identifies Key Associations with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2019 Jan 4. doi: 10.1513/AnnalsATS.201809.
    Abstract    

    Abstract available

  29. LOMBARD FW, Liang Y
    Perioperative Risk Factors for Mitral Valve Surgery: Atrial Fibrillation and Pulmonary Hypertension.
    Semin Cardiothorac Vasc Anesth. 2019 Jan 4:1089253218821694.
    Abstract    



  30. YE LF, Fan Y, Shu Q, Lin R, et al
    Management of persistent pulmonary hypertension in newborns with ECMO support: a single center's experience.
    World J Pediatr. 2019 Jan 3. pii: 10.1007/s12519-018-0215.
    Abstract    

    Abstract available

  31. SEO HS, Lee H
    Assessment of Right Ventricular Function in Pulmonary Hypertension with Multimodality Imaging.
    J Cardiovasc Imaging. 2018;26:189-200.
    Abstract    

    Abstract available

  32. WEBER U, Schiefer J, Muhlbacher J, Bernardi MH, et al
    High altitude trekking after lung transplantation: a prospective study using lung ultrasound to detect comets tails for interstitial pulmonary edema in lung transplant recipients and healthy volunteers.
    Transpl Int. 2018;31:1245-1253.
    Abstract    

    Abstract available

  33. JOPPI R, Gerardi C, Bertele' V, Garattini S, et al
    A disease looking for innovative drugs: The case of pulmonary arterial hypertension.
    Eur J Intern Med. 2018;55:47-51.
    Abstract    

    Abstract available

  34. YU FY, Yang SC, Ji ES
    [The role of adventitia in hypoxic vascular remodeling].
    Sheng Li Xue Bao. 2018;70:211-216.
    Abstract    

    Abstract available

  35. COONS JC, Miller T
    Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.
    Ther Adv Respir Dis. 2018;12:1753466618766490.
    Abstract    

    Abstract available

  36. ZAMBRANO BA, McLean NA, Zhao X, Tan JL, et al
    Image-based computational assessment of vascular wall mechanics and hemodynamics in pulmonary arterial hypertension patients.
    J Biomech. 2018;68:84-92.
    Abstract    

    Abstract available

  37. NEUMANN V, Knies R, Seidinger A, Simon A, et al
    The beta2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via alpha adrenoceptor antagonism.
    FASEB J. 2018;32:2519-2530.
    Abstract    

    Abstract available

  38. YUAN SM
    Pulmonary artery hypertension in childhood: The transforming growth factor-beta superfamily-related genes.
    Pediatr Neonatol. 2018;59:112-119.
    Abstract    

    Abstract available

  39. DE VECCHIS R, Cesaro A, Ariano C
    Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    Minerva Cardioangiol. 2018;66:659-670.
    Abstract    

    Abstract available

  40. PRINS KW, Rose L, Archer SL, Pritzker M, et al
    Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    J Am Heart Assoc. 2019;8:e011464.
    Abstract    

    Abstract available

  41. AMER R, Elsayed YN, Graham MR, Sikarwar AS, et al
    Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn.
    Pediatr Pulmonol. 2019 Jan 15. doi: 10.1002/ppul.24248.
    Abstract    

    Abstract available

  42. STYLE CC, Olutoye OO, Belfort MA, Ayres NA, et al
    Fetal endoscopic tracheal occlusion reduces pulmonary hypertension in severe congenital diaphragmatic hernia.
    Ultrasound Obstet Gynecol. 2019 Jan 14. doi: 10.1002/uog.20216.
    Abstract    

    Abstract available

  43. TRAMMELL AW, Shah AJ, Phillips LS, Hart CM, et al
    EXPRESS: Mortality in U.S. veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors.
    Pulm Circ. 2019 Jan 14:2045894019825763. doi: 10.1177/2045894019825763.
    Abstract    



  44. NELIN LD, Potenziano JL
    Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.
    BMC Pediatr. 2019;19:17.
    Abstract    

    Abstract available

  45. XU SL, Yang J, Zhang CF, Xu SY, et al
    Serum Cardiac Troponin Elevation Predicts Mortality in Patients with Pulmonary Hypertension: A Meta-Analysis of 8 Cohort Studies.
    Clin Respir J. 2019 Jan 13. doi: 10.1111/crj.12991.
    Abstract    

    Abstract available

  46. GARCIA-LUNAR I, Pereda D, Santiago E, Solanes N, et al
    Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.
    Basic Res Cardiol. 2019;114:5.
    Abstract    

    Abstract available

  47. WANG J, Yu M, Xu J, Cheng Y, et al
    Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
    J Biomed Sci. 2019;26:6.
    Abstract    

    Abstract available

  48. JONE PN, Schafer M, Pan Z, Ivy DD, et al
    Right Ventricular-Arterial Coupling Ratio Derived From 3-Dimensional Echocardiography Predicts Outcomes in Pediatric Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2019;12:e008176.
    Abstract    

    Abstract available

  49. NUNES JPL, Cunha AC, Meirinhos T, Nunes A, et al
    Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - A review.
    Autoimmun Rev. 2018;17:1186-1201.
    Abstract    

    Abstract available

  50. DAI J, Zhou Q, Chen J, Rexius-Hall ML, et al
    Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway.
    Nat Commun. 2018;9:3850.
    Abstract    

    Abstract available

  51. BIASIN V, Wygrecka M, Barnthaler T, Jandl K, et al
    Docking of Meprin alpha to Heparan Sulphate Protects the Endothelium from Inflammatory Cell Extravasation.
    Thromb Haemost. 2018;118:1790-1802.
    Abstract    

    Abstract available

  52. LULIC F, Virag Z, Jakopovic M, Korade I, et al
    Noninvasive determination of the pulmonary artery input impedance.
    Med Hypotheses. 2018;120:7-13.
    Abstract    

    Abstract available

  53. HAO X, Ma C, Chen S, Dang J, et al
    Reverse the down regulation of miR-92b-3p by hypoxia can suppress the proliferation of pulmonary artery smooth muscle cells by targeting USP28.
    Biochem Biophys Res Commun. 2018;503:3064-3077.
    Abstract    

    Abstract available

  54. XIONG W, Xu M, Pudasaini B, Guo X, et al
    The influence of anemia on one-year exacerbation rate of patients with COPD-PH.
    BMC Pulm Med. 2018;18:143.
    Abstract    

    Abstract available

  55. LUO L, Liu Y, Chen D, Chen F, et al
    CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.
    Biomed Res Int. 2018;2018:3261436.
    Abstract    

    Abstract available

  56. SAVLA JJ, Levine BD, Sadek HA
    The Effect of Hypoxia on Cardiovascular Disease: Friend or Foe?
    High Alt Med Biol. 2018;19:124-130.
    Abstract    

    Abstract available

  57. SALDANHA R, Gan M, Shitole A
    Left ventricle-right atrium shunt following mitral valve replacement.
    Asian Cardiovasc Thorac Ann. 2018;26:496-497.
    Abstract    



  58. MECOLI CA, Shah AA, Boin F, Wigley FM, et al
    Vascular complications in systemic sclerosis: a prospective cohort study.
    Clin Rheumatol. 2018;37:2429-2437.
    Abstract    

    Abstract available

  59. GAVILANES F, Piloto B, Fernandes CJC
    Giant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension.
    J Bras Pneumol. 2018;44:167.
    Abstract    



  60. MURATALI UULU K, Cholponbaeva M, Duishobaev M, Toktosunova A, et al
    A Case of Subacute Infantile Mountain Sickness in a Kyrgyz Child.
    High Alt Med Biol. 2018;19:208-210.
    Abstract    

    Abstract available

  61. BLUM LK, Cao RRL, Sweatt AJ, Bill M, et al
    Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.
    Eur J Immunol. 2018;48:874-884.
    Abstract    

    Abstract available

  62. SHI R, Wei Z, Zhu D, Fu N, et al
    Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Pulm Pharmacol Ther. 2018;48:124-135.
    Abstract    

    Abstract available

  63. GRISSOM CK, Jones BE
    Respiratory Health Benefits and Risks of Living at Moderate Altitude.
    High Alt Med Biol. 2018;19:109-115.
    Abstract    

    Abstract available

  64. BAI P, Lyu L, Yu T, Zuo C, et al
    Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-beta1 Signaling.
    Arterioscler Thromb Vasc Biol. 2019 Jan 24:ATVBAHA118312254.
    Abstract    

    Abstract available

  65. UDLAND CJ, Carey WA, Weaver AL, Mara KC, et al
    Birth Size and Gestational Age Specific Outcomes of Inhaled Nitric Oxide Therapy in Preterm Neonates with Clinically Diagnosed Pulmonary Hypertension.
    Am J Perinatol. 2019 Jan 23. doi: 10.1055/s-0039-1677799.
    Abstract    

    Abstract available

  66. COMEGLIO P, Filippi S, Sarchielli E, Morelli A, et al
    Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
    J Endocrinol Invest. 2019 Jan 23. pii: 10.1007/s40618-019-1009.
    Abstract    

    Abstract available

  67. RAN H, Schneider M, Pistritto AM, Gerges C, et al
    Echocardiographic evaluation of left ventricular filling pressures in patients with pulmonary hypertension.
    Int J Cardiovasc Imaging. 2019 Jan 21. pii: 10.1007/s10554-019-01528.
    Abstract    

    Abstract available

  68. DARWICHE T, Collum SD, Bi W, Reynolds JO, et al
    Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
    Exp Physiol. 2019 Jan 21. doi: 10.1113/EP087321.
    Abstract    

    Abstract available

  69. ABE K, Hosokawa K, Tsutsui H
    Traditional screening tool in the era of modern treatment for chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019 Jan 11. pii: S0167-5273(18)37124.
    Abstract    



  70. WATTE G, Mello M, Altmayer S, Hochhegger B, et al
    Switching from sildenafil to riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019;277:239.
    Abstract    



  71. ZUOYOU L, Shiota S, Morio Y, Sugiyama A, et al
    Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease.
    Respir Physiol Neurobiol. 2019 Jan 17. pii: S1569-9048(18)30388.
    Abstract    

    Abstract available

  72. DE LAZZARI M, Cipriani A, Rizzo S, Famoso G, et al
    Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension.
    JACC Cardiovasc Imaging. 2019 Jan 9. pii: S1936-878X(18)31089.
    Abstract    



  73. LI T, Luo XJ, Wang EL, Li NS, et al
    Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase.
    Eur J Pharmacol. 2019 Jan 16. pii: S0014-2999(19)30028.
    Abstract    

    Abstract available

  74. BAKHSHAYESHKARAM M, Aghahosseini F, Vaezi F, Kahkooei S, et al
    CT-measured pulmonary artery diameter as an independent predictor of pulmonary hypertension in cystic fibrosis.
    Pol J Radiol. 2018;83:e401-e406.
    Abstract    

    Abstract available

  75. CHOI EK, Shin SH, Kim EK, Kim HS, et al
    Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.
    BMC Pediatr. 2019;19:26.
    Abstract    

    Abstract available

  76. KECHAOU I, Boukhris I
    [Senile rheumatoid arthritis associated with rheumatoid lung: a caricatural observation].
    Pan Afr Med J. 2018;30:253.
    Abstract    

    Abstract available

  77. BASSE I, Fall AL, Seck N, Boiro D, et al
    [Interauricular communications in children: diagnosis and treatment, about 49 cases at the Children?s University Hospital in Dakar].
    Pan Afr Med J. 2018;30:245.
    Abstract    

    Abstract available

  78. SU H, Xu X, Yan C, Shi Y, et al
    LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension.
    Respir Res. 2018;19:254.
    Abstract    

    Abstract available

  79. WISUTTHATHUM S, Demougeot C, Totoson P, Adthapanyawanich K, et al
    Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension.
    Phytomedicine. 2018;50:157-165.
    Abstract    

    Abstract available

  80. FOX CJ, Cornett EM, Hart BM, Kaye AJ, et al
    Pulmonary vasodilators: Latest evidence and outcomes in the perioperative setting.
    Best Pract Res Clin Anaesthesiol. 2018;32:237-250.
    Abstract    

    Abstract available

  81. MIAO R, Wan J, Liu J, Yuan JX, et al
    Bone Marrow-Derived Endothelial Progenitor Cells Contribute to Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibition of Store-Operated Ca(2+) Channels.
    Biomed Res Int. 2018;2018:4892349.
    Abstract    

    Abstract available

  82. KUDRYASHOVA TV, Shen Y, Pena A, Cronin E, et al
    Inhibitory Antibodies against Activin A and TGF-beta Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  83. YANG YZ, Zhang YF, Yang L, Xu J, et al
    miR760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4.
    Int J Mol Med. 2018;42:2437-2446.
    Abstract    

    Abstract available

  84. PETERS EL, Comerford D, Vaz FM, van der Laarse WJ, et al
    Meijer and Vloedman's histochemical demonstration of mitochondrial coupling obeys Lambert-Beer's law in the myocardium.
    Histochem Cell Biol. 2019;151:85-90.
    Abstract    

    Abstract available

  85. HE X, Wang L, Zhu L, Yuan D, et al
    A case-control study of the genetic polymorphism of IL6 and HAPE risk in a Chinese Han population.
    Clin Respir J. 2018;12:2419-2425.
    Abstract    

    Abstract available

  86. LIU J, Fei L, Huang GQ, Shang XK, et al
    Right ventricle performances with echocardiography and (99m)Tc myocardial perfusion imaging in pulmonary arterial hypertension patients.
    Exp Biol Med (Maywood). 2018;243:754-761.
    Abstract    

    Abstract available

  87. KEMPNY A, Wort SJ, Dimopoulos K
    Balloon pulmonary angioplasty for chronic thromboembolic disease: aiming for perfection.
    EuroIntervention. 2018;13:1983-1986.
    Abstract    



  88. SUN L, Wang Y, Dong Y, Song S, et al
    Assessment of Right Atrium Function in Patients With Systemic Lupus Erythematosus With Different Pulmonary Artery Systolic Pressures by 2-Dimensional Speckle-Tracking Echocardiography.
    J Ultrasound Med. 2018;37:2345-2351.
    Abstract    

    Abstract available

  89. YU X, Chen X, Zheng XD, Zhang J, et al
    Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells.
    Hypertension. 2018;71:729-741.
    Abstract    

    Abstract available

  90. GERRINGER JW, Wagner JC, Velez-Rendon D, Valdez-Jasso D, et al
    Lumped-parameter models of the pulmonary vasculature during the progression of pulmonary arterial hypertension.
    Physiol Rep. 2018;6.
    Abstract    

    Abstract available

  91. WEISE-CROSS L, Sands MA, Sheak JR, Broughton BRS, et al
    Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.
    Am J Physiol Heart Circ Physiol. 2018;314:H1011-H1021.
    Abstract    

    Abstract available

  92. DE WIJS-MEIJLER DPM, van Duin RWB, Duncker DJ, Scherrer U, et al
    Structural and functional changes of the pulmonary vasculature after hypoxia exposure in the neonatal period: a new swine model of pulmonary vascular disease.
    Am J Physiol Heart Circ Physiol. 2018;314:H603-H615.
    Abstract    

    Abstract available

  93. RAFIKOV R, McBride ML, Zemskova M, Kurdyukov S, et al
    INOSITOL MONOPHOSPHATASE 1 (IMPA1) AS A NOVEL INTERACTING PARTNER OF RAGE IN PULMONARY HYPERTENSION.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jan 3. doi: 10.1152/ajplung.00393.2018.
    Abstract    

    Abstract available

  94. ZHANG R, Su H, Ma X, Xu X, et al
    MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jan 10. doi: 10.1152/ajplung.00387.2018
    Abstract    

    Abstract available

  95. CHAUDHARY KR, Stewart DJ
    Go with the (back) flow: what can retrograde perfusion teach us about arterial remodeling in pulmonary arterial hypertension?
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L797-L798.
    Abstract    



  96. YADAV VR, Song T, Mei L, Joseph L, et al
    PLCgamma1-PKCepsilon-IP3R1 signaling plays an important role in hypoxia-induced calcium response in pulmonary artery smooth muscle cells.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L724-L735.
    Abstract    

    Abstract available

  97. SURESH K, Servinsky L, Jiang H, Bigham Z, et al
    Reactive oxygen species induced Ca(2+) influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L893-L907.
    Abstract    

    Abstract available

  98. LU Q, Gottlieb E, Rounds S
    Effects of cigarette smoke on pulmonary endothelial cells.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L743-L756.
    Abstract    

    Abstract available

  99. ZHOU C, Crockett ES, Batten L, McMurtry IF, et al
    Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L835-L845.
    Abstract    

    Abstract available

  100. YEE M, Cohen ED, Domm W, Porter GA Jr, et al
    Neonatal hyperoxia depletes pulmonary vein cardiomyocytes in adult mice via mitochondrial oxidation.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L846-L859.
    Abstract    

    Abstract available

  101. SYSOL JR, Chen J, Singla S, Zhao S, et al
    Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L461-L472.
    Abstract    

    Abstract available

  102. LI HH, Hsu HH, Chang GJ, Chen IC, et al
    Prostanoid EP4 agonist L-902,688 activates PPARgamma and attenuates pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L349-L359.
    Abstract    

    Abstract available

  103. BLISSENBACH B, Nakas CT, Kronke M, Geiser T, et al
    Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L157-L164.
    Abstract    

    Abstract available

  104. SUZUKI T, Carrier EJ, Talati MH, Rathinasabapathy A, et al
    Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L118-L126.
    Abstract    

    Abstract available

  105. BARRETO ORTIZ S, Hori D, Nomura Y, Yun X, et al
    Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L93-L106.
    Abstract    

    Abstract available

  106. BEYER C, Huscher D, Ramming A, Bergmann C, et al
    Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.
    Ann Rheum Dis. 2018;77:626-628.
    Abstract    



  107. TU L, Castan A, Mallet C, Guyon L, et al
    Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
    Circ Res. 2019 Jan 14. doi: 10.1161/CIRCRESAHA.118.313356.
    Abstract    

    Abstract available

  108. BABICHEVA A, Yuan JX
    Endothelial Notch1 in Pulmonary Hypertension.
    Circ Res. 2019;124:176-179.
    Abstract    




  109. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    Abstract    



  110. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  111. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  112. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  113. CONDLIFFE R, Kovacs G
    Identifying early pulmonary arterial hypertension in patients with systemic sclerosis.
    Eur Respir J. 2018;51.
    Abstract    



  114. NEWNHAM M, South K, Bleda M, Auger WR, et al
    The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01805-2018.
    Abstract    

    Abstract available

  115. ELHASSAN A, Essandoh M
    Inhaled Levosimendan for Pulmonary Hypertension Treatment During Cardiac Surgery: A Novel Application to Avoid Systemic Hypotension.
    J Cardiothorac Vasc Anesth. 2018 Nov 28. pii: S1053-0770(18)31091.
    Abstract    



  116. BOISEN ML, Sardesai MP, Kolarczyk L, Rao VK, et al
    The Year in Thoracic Anesthesia: Selected Highlights From 2017.
    J Cardiothorac Vasc Anesth. 2018 Mar 13. pii: S1053-0770(18)30189.
    Abstract    



  117. GREAVES SW, Dye L 3rd, Aranda PS, Cain MT, et al
    Perioperative Management of a Large Idiopathic Pulmonary Artery Aneurysm Without Pulmonary Arterial Hypertension.
    J Cardiothorac Vasc Anesth. 2018;32:2402-2408.
    Abstract    



  118. ALTIT G, Bhombal S, Hopper RK, Tacy TA, et al
    Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.
    J Perinatol. 2019 Jan 7. pii: 10.1038/s41372-018-0303.
    Abstract    

    Abstract available

  119. LOISEL F, Provost B, Guihaire J, Boulate D, et al
    Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019;157:655-666.
    Abstract    

    Abstract available

  120. MILARA J, Ballester B, Morell A, Ortiz JL, et al
    JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
    Thorax. 2018;73:519-529.
    Abstract    

    Abstract available

  121. UENO T, Hiwatashi S, Saka R, Yamanaka H, et al
    Pulmonary Arterial Pressure Management Based on Oral Medicine for Pediatric Living Donor Liver Transplant With Portopulmonary Hypertension.
    Transplant Proc. 2018 Mar 15. pii: S0041-1345(18)30401.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;